The DOI matches its Crossref record.
Cost effectiveness analysis of screening for sight threatening diabetic eye disease
Open accessAbstract
OBJECTIVE: To measure the cost effectiveness of systematic photographic screening for sight threatening diabetic eye disease compared with existing practice. DESIGN: Cost effectiveness analysis. SETTING: Liverpool. SUBJECTS: A target population of 5000 diabetic patients invited for screening. MAIN OUTCOME MEASURES: Cost effectiveness (cost per true positive) of systematic and opportunistic programmes; incremental cost effectiveness of replacing opportunistic with systematic screening. RESULTS: Baseline prevalence of sight threatening eye disease was 14.1%. The cost effectiveness of the systematic programme was 209 pound sterling (sensitivity 89%, specificity 86%, compliance 80%, annual cost 104996 pound sterling) and of the opportunistic programme was 289 pound sterling (combined sensitivity 63%, specificity 92%, compliance 78%, annual cost 99 981 pound sterling). The incremental cost effectiveness of completely replacing the opportunistic programme was 32 pound sterling. Absolute values of cost effectiveness were highly sensitive to varying prevalence, sensitivity and specificity, compliance, and programme size. CONCLUSION: Replacing existing programmes with systematic screening for diabetic eye disease is justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
Ting, D. S. W., Cheung, G. C. M., & Wong, T. Y. (2016) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12696 · Cited by 1,066
Lin, D. Y., Blumenkranz, M. S., Brothers, R. J., & Grosvenor, D. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01522-2 · Cited by 327
Younis, N., Broadbent, D. M., Vora, J. P., & Harding, S. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12267-2 · Cited by 289
Diabetic retinopathy screening: a systematic review of the economic evidence
Jones, S., & Edwards, R. T. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02870.x · Cited by 265
Metadata
- Authors
- James, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-06-17
- Volume
- 320
- Issue
- 7250
- Pages
- 1627-1631
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2036504612
- Cited by
- 168
- References
- 0
- FWCI
- 16.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost effectiveness analysis of screening for sight threatening diabetic eye disease. https://app.cochat.ai/papers/10.1136/bmj.320.7250.1627
- The paper
- James, M. (2000). Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. https://doi.org/10.1136/bmj.320.7250.1627
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.